CLINICAL ROLE -
July 29th 2025
The supplements were also linked to improvements in pain and disease activity markers.
July 24th 2025
There were also no observed differences in retention rates or safety among patients with ankylosing spondylitis.
April 28th 2025
Patients Should Also Have a Diet Rich in Fruits, Oily Fish, and Cereals
April 3rd 2025
Tocilizumab-bavi received FDA approval in September 2023 as the first biosimilar to tocilizumab for the treatment of various adult and pediatric arthritis conditions.
February 24th 2025
Although more research is needed in pediatric patients, biosimilars could improve treatment access and reduce costs.
Remicade Biosimilar Set for US Launch Next Month
Inflectra is the first biosimilar monoclonal antibody approved by the FDA.
Read More
Trending News Today: Biosimilar Savings Lag Behind Expectations
Top news of the day from across the health care landscape.
Common Rheumatoid Arthritis Drug Effective in Treating Rare Eye Disease
Adalimumab also found to be effective in treating non-infectious uveitis.
Baricitinib for Rheumatoid Arthritis More Effective Than Methotrexate
Baricitinib monotherapy or in combination with methotrexate shows superiority treating rheumatoid arthritis.
JAK Inhibitor Shows Superiority in Active Rheumatoid Arthritis
Investigational drug used alone or in combination demonstrated superiority to methotrexate in patients with active rheumatoid arthritis.
Almost Half of Rheumatoid Arthritis Patients Discontinued Xeljanz Within a Year
Adherence programs needed to boost Xeljanz utilization for rheumatoid arthritis.
Humira Biosimilar Approved, But Not Interchangeable
Amgen’s biosimilar Amjevita approved for variety of anti-inflammatory diseases, however, ongoing litigation may prevent it from hitting the market.
Express Scripts Creates Outcomes-Based Payment Model
Refunds will be offered to plan sponsors if a patient discontinues a preferred anti-inflammatory drug within 90 days.
Enbrel Biosimilar Gains FDA Approval
Erelzi, an etanercept biosimilar, was approved for rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and polyarticular juvenile idiopathic arthritis.
FDA Approves Biosimilar for Enbrel
Sandoz has gained FDA-approval for Erelzi, an etanercept biosimilar.
Link Found Between Rheumatoid Arthritis Drug and Flesh-Eating Infection
Patients taking medication that inhibits IL-1beta are 300 times more likely to develop a flesh-eating infection.
Trending News Today: Judge Rules Remicade Patent is Invalid
Trending News Today: Harnessing Technology to Fight Cancer
AbbVie Employs Delay Tactics for Humira Biosimilar
AbbVie alleges that Amgen is infringing on 61 patents with their biosimilar.
Anti-Interferon Autoantibodies Could Protect Against Diabetes
A small proportion of patients with autoimmune syndrome have diabetes.
Inflammatory Biosimilar Comparable to Branded Biologic
Biosimilar to rheumatoid arthritis and inflammatory bowel disease drug shows similar efficacy to brand name drug.
Trending News Today: Improvements in Veterans Health Care Delivery
Top news from across the health care landscape.
Gut Bacteria May Influence Rheumatoid Arthritis Treatment
Intestinal microbiota may help predict rheumatoid arthritis symptom severity and frequency.
Myeloma Could Potentially Be Caused by a Benign Condition
Approximately 1 in 100 patients with MGUS develop myeloma.
Nerve Stimulation Reduces Rheumatoid Arthritis Symptoms
Vagus nerve stimulation may prove an effective RA treatment strategy.
Biologic Autoinjector for Rheumatoid Arthritis Launches
Orencia ClickJect Autoinjector has an ergonomic design that may be beneficial for patients.
Bristol-Myers Squibb Launches Biologic Autoinjector for Rheumatoid Arthritis
What's So Special About Specialty Pharmacy
Is the cost of specialty drugs worth the price in small patient populations?
The Impact of Smoking and Obesity on Rheumatoid Arthritis Treatment
Body mass index and smoking could have significant impact on RA remission.
Autoimmune Diseases May Limit Lung Cancer Patient Eligibility for Immunotherapy
Immunotherapy for lung cancer patients may cause other conditions to become worse.
Nanoparticles Show Promise in Long-Term Treatment of Rheumatoid Arthritis
Biodegradable polymer nanoparticles to deliver methotrexate may improve rheumatoid arthritis therapy.
Determining Treatment Response to Rheumatoid Arthritis Drugs
Presence of different antibodies in the blood can influence response to abatacept regimen.
FDA to Review Humira Biosimilar
Anti-TNF-a monoclonal antibody treats moderate-to-severe plaque psoriasis and moderate-to-severe rheumatoid arthritis.
Heavy Physical Workload Linked to Development of Rheumatoid Arthritis
Some types of physical activity may increase the risk of rheumatoid arthritis.